STOCK TITAN

Terumo Corporation - TRUMY STOCK NEWS

Welcome to our dedicated news page for Terumo Corporation (Ticker: TRUMY), a resource for investors and traders seeking the latest updates and insights on Terumo Corporation.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Terumo Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Terumo Corporation's position in the market.

Rhea-AI Summary
Terumo Medical Corporation (TIS) introduces the AZUR HydroPack Peripheral Coil System, a versatile soft coil with hydrogel technology for embolization, offering optimized stability and precise delivery. The coil is FDA-cleared, with a true .018" primary wind and is available in long lengths, making it the longest gel core coil on the market, allowing for flexible sizing and deployment through microcatheters. The hydrogel technology promotes new tissue growth and tight packing, putting the system in a category of its own in the peripheral coil market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
none
-
Rhea-AI Summary
IceCure Medical participated in a cryoablation symposium in Thailand, showcasing its ProSense System. Professor Fukuma, who has performed over 600 procedures with ProSense, praised its effectiveness and minimal side effects. The partnership between IceCure and Terumo Thailand is expected to improve sales momentum. The growing data on ProSense's efficacy supports its use in treating breast, lung, and kidney tumors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
none
-
Rhea-AI Summary
IceCure Medical participated in a cryoablation symposium in Thailand, showcasing its ProSense System. Professor Fukuma, who has performed over 600 procedures with ProSense, praised its effectiveness and minimal side effects. The partnership between IceCure and Terumo Thailand is expected to improve sales momentum. The growing data on ProSense's efficacy supports its use in treating breast, lung, and kidney tumors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.76%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.78%
Tags
none
Terumo Corporation

OTC:TRUMY

TRUMY Rankings

TRUMY Stock Data

27.74B
728.09M
0%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Japan
Shibuya Ku